CY1112212T1 - NEW VEGETABLE FORMATS OF VOLUME CONNECTED WITH PARTICULARS OF ANTI-HUMAN LEVEL CELLS (HLA) CLASS I OR II - Google Patents

NEW VEGETABLE FORMATS OF VOLUME CONNECTED WITH PARTICULARS OF ANTI-HUMAN LEVEL CELLS (HLA) CLASS I OR II

Info

Publication number
CY1112212T1
CY1112212T1 CY20121100003T CY121100003T CY1112212T1 CY 1112212 T1 CY1112212 T1 CY 1112212T1 CY 20121100003 T CY20121100003 T CY 20121100003T CY 121100003 T CY121100003 T CY 121100003T CY 1112212 T1 CY1112212 T1 CY 1112212T1
Authority
CY
Cyprus
Prior art keywords
hla
class
particulars
formats
level cells
Prior art date
Application number
CY20121100003T
Other languages
Greek (el)
Inventor
Peter Lewandrowski
Christian Flohr
Original Assignee
Immatics Biotechnologies Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP08008292A external-priority patent/EP2113253B1/en
Application filed by Immatics Biotechnologies Gmbh filed Critical Immatics Biotechnologies Gmbh
Publication of CY1112212T1 publication Critical patent/CY1112212T1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)

Abstract

Η παρούσα εφεύρεση αφορά νέα σκευάσματα πεπτιδίων που σχετίζονται με όγκους τα οποία συνδέονται σε μόρια του αντιγόνου ανθρώπινων λευκοκυττάρων (HLA) Τάξης I ή II ως εμβόλια για χρήση σε ανοσοθεραπευτικές μεθόδους. Συγκεκριμένα, η παρούσα εφεύρεση σχετίζεται με σκευάσματα για την ανοσοθεραπεία του καρκίνου, και συγκεκριμένα καρκίνο του νεφρού και του εγκεφάλου, και συγκεκριμένα γλοίωμα, ειδικότερα γλοιοβλάστωμα καρκίνου. Η παρούσα εφεύρεση αφορά επιπλέον συνθέσεις εμβολίων για να επιφέρουν αντικαρκινικές ανοσοαπαντήσεις.The present invention relates to novel formulations of tumor-associated peptides that bind to Class I or II human leukocyte antigen (HLA) molecules as vaccines for use in immunotherapeutic methods. In particular, the present invention relates to formulations for cancer immunotherapy, in particular kidney and brain cancer, and in particular glioma, in particular glioblastoma of cancer. The present invention relates to further vaccine compositions to induce anti-cancer immune responses.

CY20121100003T 2008-04-24 2012-01-03 NEW VEGETABLE FORMATS OF VOLUME CONNECTED WITH PARTICULARS OF ANTI-HUMAN LEVEL CELLS (HLA) CLASS I OR II CY1112212T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4766908P 2008-04-24 2008-04-24
EP08008292A EP2113253B1 (en) 2008-04-30 2008-04-30 Novel formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules for vaccines
EP09005725A EP2111867B1 (en) 2008-04-24 2009-04-23 Novel formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules for vaccines

Publications (1)

Publication Number Publication Date
CY1112212T1 true CY1112212T1 (en) 2015-12-09

Family

ID=47785995

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20121100003T CY1112212T1 (en) 2008-04-24 2012-01-03 NEW VEGETABLE FORMATS OF VOLUME CONNECTED WITH PARTICULARS OF ANTI-HUMAN LEVEL CELLS (HLA) CLASS I OR II

Country Status (3)

Country Link
JP (1) JP5921395B2 (en)
CY (1) CY1112212T1 (en)
HK (1) HK1223290A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102416176A (en) * 1995-07-27 2012-04-18 基因技术股份有限公司 Stabile isotonic lyophilized protein formulation
AU2004229458B2 (en) * 2003-04-11 2009-11-19 Antigenics, Inc. Improved heat shock protein-based vaccines and immunotherapies
AR048098A1 (en) * 2004-03-15 2006-03-29 Wyeth Corp CALIQUEAMYCIN CONJUGATES
SI1760089T1 (en) * 2005-09-05 2009-12-31 Immatics Biotechnologies Gmbh Tumor-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules and related anti-cancer vaccine
PL2113253T3 (en) * 2008-04-30 2010-09-30 Immatics Biotechnologies Gmbh Novel formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules for vaccines

Also Published As

Publication number Publication date
JP2013028621A (en) 2013-02-07
HK1223290A1 (en) 2017-07-28
JP5921395B2 (en) 2016-05-24

Similar Documents

Publication Publication Date Title
CY1110178T1 (en) NEW VEGETABLE PEPPER CONNECTIONS CONCLUDED IN PARTICULARS OF HLA LEVEL I OR I
CY1119739T1 (en) Innovative Immunotherapy Against Brain Tumors
CY1118702T1 (en) COMPOSITION OF VOLUMES CONCERNING VOLUME AND RELATED Cancer Vaccine for Glioblastoma Therapy (GLIOBLASTOMA, GBM)
CY1115999T1 (en) NEW AND POWERFUL MHC-CATEGORY II PURPOSES FROM SURBIVIN AND NEUROCANE
CY1113062T1 (en) TUMORS RELATED TO TUMORS CONNECTED WITH PARTICULARS OF HUMAN LEVEL CELLS (HLA) CLASS I OR II AND RELATED ANTIQUES
MD3331900T2 (en) Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
CY1110051T1 (en) TUMORS RELATED TO TUMORS CONNECTED IN PARTICULARS OF THE HLA CLASS II ANTI-HUMAN ANTIGEN
CY1117115T1 (en) Innovative Immunotherapy Against Tumors And Neurons Of The Brain
CY1119941T1 (en) STABLE AND SOLUBLE PARTS
MD3319985T2 (en) Novel peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers
CY1124847T1 (en) NOVEL PEPTIDES AND PEPTIDE COMBINATIONS FOR USE IN IMMUNOTHERAPY AGAINST HEPATO CELL CARCINOMA (HCC) AND OTHER CANCER
UA104572C2 (en) Novel formulations of tumour-associated peptides binding to human leukocyte antigen (hla) class i or ii molecules for vaccines
CY1112212T1 (en) NEW VEGETABLE FORMATS OF VOLUME CONNECTED WITH PARTICULARS OF ANTI-HUMAN LEVEL CELLS (HLA) CLASS I OR II
CY1116819T1 (en) Innovative Immunotherapy Against Different Tumors Including Gastrointestinal and Gastric Cancer